Saurabh Agarwal

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Childhood Cancer

Histone Deacetylase

Top Venues

Current oncology (Toronto, Ont.)

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Saurabh Agarwal
Pediatric Cancers: Insights and Novel Therapeutic Approaches. Cancers 15 (14) (2023)
Vineela Parvathaneni, Rameswari Chilamakuri, Nishant S Kulkarni, Nabeela F Baig, Saurabh Agarwal, Vivek Gupta
Exploring Amodiaquine's Repurposing Potential in Breast Cancer Treatment-Assessment of In-Vitro Efficacy & Mechanism of Action. International journal of molecular sciences 23 (19) (2022)
Rameswari Chilamakuri, Danielle Crystal Rouse, Saurabh Agarwal
Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth. Pharmaceuticals (Basel, Switzerland) 15 (5) (2022)
Rameswari Chilamakuri, Saurabh Agarwal
Direct Targeting of the Raf-MEK-ERK Signaling Cascade Inhibits Neuroblastoma Growth. Current oncology (Toronto, Ont.) 29 (9) (2022)
Yang Yu, Yanling Zhao, Jong Min Choi, Zhongcheng Shi, Linjie Guo, John Elizarraras, Andy Gu, Feng Cheng, Yanxin Pei, Dai Lu, Muller Fabbri, Saurabh Agarwal, Chunchao Zhang, Sung Yun Jung, Jennifer H Foster, Jianhua Yang
ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo. Cancers 14 (22) (2022)
Rameswari Chilamakuri, Saurabh Agarwal
Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth. Cancers 14 (4) (2022)
Rameswari Chilamakuri, Saurabh Agarwal
COVID-19: Characteristics and Therapeutics. Cells 10 (2) (2021)